Proteaza HIV-1 (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Proteaza HIV-1" in Polish language version.

refsWebsite

Global rank Polish rank

7doi.org

2^nd place

6^th place

4worldcat.org

5^th place

2^nd place

3nih.gov

4^th place

7^th place

2elsevier.com

610^th place

682^nd place

1expasy.org

7,021^st place

751^st place

doi.org

dx.doi.org

A.H.A.H. Kaplan A.H.A.H., R.R. Swanstrom R.R., Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments., „Proceedings of the National Academy of Sciences of the United States of America”, 88 (10), 1991, s. 4528–4532, DOI: 10.1073/pnas.88.10.4528, ISSN 0027-8424, PMID: 2034693 (ang.).
R. RenaeR.R. Speck R. RenaeR.R. i inni, Comparison of Human Immunodeficiency Virus Type 1 Pr55^Gag and Pr160^Gag-Pol Processing Intermediates That Accumulate in Primary and Transformed Cells Treated with Peptidic and Nonpeptidic Protease Inhibitors, „Antimicrobial Agents and Chemotherapy”, 44 (5), 2000, s. 1397–1403, DOI: 10.1128/AAC.44.5.1397-1403.2000, ISSN 0066-4804, PMID: 10770790 (ang.).
AshrafA. Brik AshrafA., Chi-HueyCh.H. Wong Chi-HueyCh.H., HIV-1 protease: mechanism and drug discovery, „Organic & Biomolecular Chemistry”, 1 (1), 2003, s. 5–14, DOI: 10.1039/b208248a, ISSN 1477-0539 (ang.).
Walter R.P.W.R.P. Scott Walter R.P.W.R.P., Celia A.C.A. Schiffer Celia A.C.A., Curling of Flap Tips in HIV-1 Protease as a Mechanism for Substrate Entry and Tolerance of Drug Resistance, „Structure”, 8 (12), 2000, s. 1259–1265, DOI: 10.1016/S0969-2126(00)00537-2, ISSN 0969-2126, PMID: 11188690 .
JeffreyJ. Stebbins JeffreyJ. i inni, The 80’s loop (residues 78 to 85) is important for the differential activity of retroviral proteases 1 1Edited by A. R. Fresht, „Journal of Molecular Biology”, 267 (3), 1997, s. 467–475, DOI: 10.1006/jmbi.1997.0891 [dostęp 2024-03-31] (ang.).
AlexanderA. Wlodawer AlexanderA., John W.J.W. Erickson John W.J.W., Structure-Based Inhibitors of HIV-1 Protease, t. 62, lipiec 1993, s. 543-585, DOI: 10.1146/annurev.bi.62.070193.002551 (ang.).
Erik DeE.D. Clercq Erik DeE.D., Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV, „International Journal of Antimicrobial Agents”, 33 (4), 2009, s. 307–320, DOI: 10.1016/j.ijantimicag.2008.10.010 [dostęp 2024-03-31] (ang.).

elsevier.com

linkinghub.elsevier.com

JeffreyJ. Stebbins JeffreyJ. i inni, The 80’s loop (residues 78 to 85) is important for the differential activity of retroviral proteases 1 1Edited by A. R. Fresht, „Journal of Molecular Biology”, 267 (3), 1997, s. 467–475, DOI: 10.1006/jmbi.1997.0891 [dostęp 2024-03-31] (ang.).
Erik DeE.D. Clercq Erik DeE.D., Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV, „International Journal of Antimicrobial Agents”, 33 (4), 2009, s. 307–320, DOI: 10.1016/j.ijantimicag.2008.10.010 [dostęp 2024-03-31] (ang.).

expasy.org

enzyme.expasy.org

Numer EC 3.4.21.4 w bazie Enzyme nomenclature database.

nih.gov

ncbi.nlm.nih.gov

A.H.A.H. Kaplan A.H.A.H., R.R. Swanstrom R.R., Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments., „Proceedings of the National Academy of Sciences of the United States of America”, 88 (10), 1991, s. 4528–4532, DOI: 10.1073/pnas.88.10.4528, ISSN 0027-8424, PMID: 2034693 (ang.).
R. RenaeR.R. Speck R. RenaeR.R. i inni, Comparison of Human Immunodeficiency Virus Type 1 Pr55^Gag and Pr160^Gag-Pol Processing Intermediates That Accumulate in Primary and Transformed Cells Treated with Peptidic and Nonpeptidic Protease Inhibitors, „Antimicrobial Agents and Chemotherapy”, 44 (5), 2000, s. 1397–1403, DOI: 10.1128/AAC.44.5.1397-1403.2000, ISSN 0066-4804, PMID: 10770790 (ang.).
Walter R.P.W.R.P. Scott Walter R.P.W.R.P., Celia A.C.A. Schiffer Celia A.C.A., Curling of Flap Tips in HIV-1 Protease as a Mechanism for Substrate Entry and Tolerance of Drug Resistance, „Structure”, 8 (12), 2000, s. 1259–1265, DOI: 10.1016/S0969-2126(00)00537-2, ISSN 0969-2126, PMID: 11188690 .

worldcat.org

A.H.A.H. Kaplan A.H.A.H., R.R. Swanstrom R.R., Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments., „Proceedings of the National Academy of Sciences of the United States of America”, 88 (10), 1991, s. 4528–4532, DOI: 10.1073/pnas.88.10.4528, ISSN 0027-8424, PMID: 2034693 (ang.).
R. RenaeR.R. Speck R. RenaeR.R. i inni, Comparison of Human Immunodeficiency Virus Type 1 Pr55^Gag and Pr160^Gag-Pol Processing Intermediates That Accumulate in Primary and Transformed Cells Treated with Peptidic and Nonpeptidic Protease Inhibitors, „Antimicrobial Agents and Chemotherapy”, 44 (5), 2000, s. 1397–1403, DOI: 10.1128/AAC.44.5.1397-1403.2000, ISSN 0066-4804, PMID: 10770790 (ang.).
AshrafA. Brik AshrafA., Chi-HueyCh.H. Wong Chi-HueyCh.H., HIV-1 protease: mechanism and drug discovery, „Organic & Biomolecular Chemistry”, 1 (1), 2003, s. 5–14, DOI: 10.1039/b208248a, ISSN 1477-0539 (ang.).
Walter R.P.W.R.P. Scott Walter R.P.W.R.P., Celia A.C.A. Schiffer Celia A.C.A., Curling of Flap Tips in HIV-1 Protease as a Mechanism for Substrate Entry and Tolerance of Drug Resistance, „Structure”, 8 (12), 2000, s. 1259–1265, DOI: 10.1016/S0969-2126(00)00537-2, ISSN 0969-2126, PMID: 11188690 .